CERS1 and central nervous system cancer: Wang et al. [32] confirmed that the concentration of C18-ceramide synthesized by CERS1 was significantly lower in glioma tissues than in normal tissues and that CERS1 overexpression in glioma cells could inhibit cell proliferation and promote cell death by activating the endoplasmic reticulum stress response.